When Johnson & Johnson’s multiple myeloma franchise Darzalex (daratumumab) generated roughly $10 billion in global revenue in 2024, it stood […]

We rarely know where our medicines originate. The global pharmaceutical supply chain is an opaque network of chemical synthesis facilities,

1. Why Patent Expiry Forecasting Is a Revenue-Critical Discipline ‘Between 2025 and 2030, approximately 190 drugs will lose market exclusivity,

1. The $2.8 Trillion Arithmetic: Market Structure and Strategic Stakes The global pharmaceutical market reached approximately $1.6 trillion in 2024

A deep dive covering the ANDA pathway, EU MAA procedures, bioequivalence science, Paragraph IV litigation strategy, patent cliff analysis, evergreening

The $236 Billion Race Most Procurement Teams Are Losing Between 2025 and 2030, more than $236 billion in branded pharmaceutical

I. Market Context: Why the CDMO Sector Is Repricing The global pharmaceutical CDMO market hit approximately $181.93 billion in 2025,

1. The Cliff Everyone Sees Coming — and Still Falls Off Every branded pharmaceutical product carries a date of death.

An investigative analysis of patent thickets, design-around strategies, and competitive intelligence for pharmaceutical generics manufacturers The Wall Every Generic Manufacturer